DOI . ORG {}

Analyzed Page
Matching Content Categories
CMS
Monthly Traffic Estimate
How Does Doi.org Make Money
Keywords
Topics
Schema
External Links
Analytics And Tracking
Libraries
Hosting Providers
CDN Services

We began analyzing https://link.springer.com/article/10.1007/s11064-011-0561-8, but it redirected us to https://link.springer.com/article/10.1007/s11064-011-0561-8. The analysis below is for the second page.

Title[redir]:
Resveratrol Pretreatment Attenuates Cerebral Ischemic Injury by Upregulating Expression of Transcription Factor Nrf2 and HO-1 in Rats | Neurochemical Research
Description:
Oxidative stress damage plays a vital role in cerebral ischemia/reperfusion (I/R) pathogenesis. The nuclear factor erythroid 2-related factor 2 (Nrf2)/antioxidant response element (ARE) signaling pathway can be activated by pharmacological and dietary means to attenuate cellular oxidative stress. Resveratrol, a plant-derived polyphenolic compound, has antioxidant property. Recent studies have demonstrated that resveratrol has protective effects against cerebral I/R injury. However, little is known about its mechanism. Hence, this study identified the neuroprotective effect of resveratrol pretreatment and elucidate the Nrf2/ARE signaling mechanism after focal cerebral I/R injury in rats. Adult male Sprague–Dawley rats were randomly assigned to sham-operated group, ischemia/reperfusion physiological saline-treated group, and ischemia/reperfusion resveratrol-pretreatmented (15 and 30 mg/kg) groups. Rats were pretreatmented with resveratrol or physiological saline of corresponding volume administered intraperitoneally for 7 days before surgery and 30 min before middle cerebral artery occlusion. At 24 h after reperfusion, neurological score, infarct volume, and brain water content were assessed. Oxidative stress was evaluated by malondialdehyde (MDA) levels and superoxide dismutase (SOD) activity. Pathological changes of brain tissue were observed by HE staining. RT-PCR and Western blot analysed the expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1). TUNEL staining detected apoptotic cells. The protein expression of Caspase-3 were studied by immunohistochemistry. Resveratrol pretreatment significantly ameliorated neurological scores, reduced infarct volume and brain water content, decreased MDA levels, restored the SOD activity, upregulated the protein and mRNA expression of Nrf2 and HO-1, downregulated the protein expression of caspase-3. TUNEL-positive cells significantly decreased compared with the physiological saline-treated group. HE staining also showed that resveratrol significantly improved neuronal injury. These results showed that resveratrol pretreatment had neuroprotective effects on cerebral I/R injury. This neuroprotective effect is likely exerted by upregulated expression of transcription factor Nrf2 and HO-1 to ameliorate oxidative damage, decreased the protein expression of caspase-3. Our finding is important for understanding the neuroprotective mechanism of resveratrol and promoting its clinical therapeutic utility.

Matching Content Categories {📚}

Education
Health & Fitness
Insurance

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month

Based on our best estimate, this website will receive around 80,479,999 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We can't see how the site brings in money.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Doi.org could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

article, google, scholar, pubmed, cas, resveratrol, cerebral, injury, brain, factor, ischemic, nrf, rats, ischemiareperfusion, expression, oxidative, res, attenuates, ischemia, stroke, protects, content, transcription, damage, antioxidant, effects, focal, protection, stress, neuroprotective, mechanisms, privacy, cookies, research, pretreatment, related, protein, caspase, chongqing, publish, search, volume, ren, fan, chen, yang, pathway, mechanism, group, activity,

Topics {✒️}

oxidative stress-inducible genes month download article/chapter cerebral ischemia-reperfusion injur neonatal cerebral hypoxia-ischemia physiological saline-treated group oxidized ldl-induced breakage plant-derived polyphenolic compound catechol-type electrophilic compound ischemia/reperfusion resveratrol-pretreatmented nrf2-regulated genes induced cerebral ischemia/reperfusion focal cerebral ischemia ischemia–reperfusion injury ischemia reperfusion injury ischemia/reperfusion injury ischemia-reperfusion injury transcription factor nrf2 full article pdf nrf2-mediated transcription ameliorate oxidative damage hypoxic-ischemic injury de oliveira ac related subjects traditional risk factors privacy choices/manage cookies /antioxidant response element ischemic brain damage oxidative stress antioxidant action ischemic brain edema ischemic brain diseases nmda-induced neurotoxicity qin yang curcumin improves outcomes resveratrol pretreatment free radical formation sham-operated group article ren focal cerebral european economic area western blot analysed pro-oxidant agent smilacis chinae rhizome induces messenger rna chemopreventive agent sulforaphane perfusion mri study ischemia-reperfusion cerebral ischemia protects rat brains experimental ischemic stroke

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Resveratrol Pretreatment Attenuates Cerebral Ischemic Injury by Upregulating Expression of Transcription Factor Nrf2 and HO-1 in Rats
         description:Oxidative stress damage plays a vital role in cerebral ischemia/reperfusion (I/R) pathogenesis. The nuclear factor erythroid 2-related factor 2 (Nrf2)/antioxidant response element (ARE) signaling pathway can be activated by pharmacological and dietary means to attenuate cellular oxidative stress. Resveratrol, a plant-derived polyphenolic compound, has antioxidant property. Recent studies have demonstrated that resveratrol has protective effects against cerebral I/R injury. However, little is known about its mechanism. Hence, this study identified the neuroprotective effect of resveratrol pretreatment and elucidate the Nrf2/ARE signaling mechanism after focal cerebral I/R injury in rats. Adult male Sprague–Dawley rats were randomly assigned to sham-operated group, ischemia/reperfusion physiological saline-treated group, and ischemia/reperfusion resveratrol-pretreatmented (15 and 30 mg/kg) groups. Rats were pretreatmented with resveratrol or physiological saline of corresponding volume administered intraperitoneally for 7 days before surgery and 30 min before middle cerebral artery occlusion. At 24 h after reperfusion, neurological score, infarct volume, and brain water content were assessed. Oxidative stress was evaluated by malondialdehyde (MDA) levels and superoxide dismutase (SOD) activity. Pathological changes of brain tissue were observed by HE staining. RT-PCR and Western blot analysed the expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1). TUNEL staining detected apoptotic cells. The protein expression of Caspase-3 were studied by immunohistochemistry. Resveratrol pretreatment significantly ameliorated neurological scores, reduced infarct volume and brain water content, decreased MDA levels, restored the SOD activity, upregulated the protein and mRNA expression of Nrf2 and HO-1, downregulated the protein expression of caspase-3. TUNEL-positive cells significantly decreased compared with the physiological saline-treated group. HE staining also showed that resveratrol significantly improved neuronal injury. These results showed that resveratrol pretreatment had neuroprotective effects on cerebral I/R injury. This neuroprotective effect is likely exerted by upregulated expression of transcription factor Nrf2 and HO-1 to ameliorate oxidative damage, decreased the protein expression of caspase-3. Our finding is important for understanding the neuroprotective mechanism of resveratrol and promoting its clinical therapeutic utility.
         datePublished:2011-08-18T00:00:00Z
         dateModified:2011-08-18T00:00:00Z
         pageStart:2352
         pageEnd:2362
         sameAs:https://doi.org/10.1007/s11064-011-0561-8
         keywords:
            Resveratrol
            Cerebral ischemia/reperfusion
            Oxidative stress
            Neuroprotection
            Nuclear factor erythroid 2-related factor 2 (Nrf2)
            Heme oxygenase 1 (HO-1)
            Caspase-3
            Neurosciences
            Neurochemistry
            Biochemistry
            general
            Cell Biology
            Neurology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11064-011-0561-8/MediaObjects/11064_2011_561_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11064-011-0561-8/MediaObjects/11064_2011_561_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11064-011-0561-8/MediaObjects/11064_2011_561_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11064-011-0561-8/MediaObjects/11064_2011_561_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11064-011-0561-8/MediaObjects/11064_2011_561_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11064-011-0561-8/MediaObjects/11064_2011_561_Fig6_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11064-011-0561-8/MediaObjects/11064_2011_561_Fig7_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11064-011-0561-8/MediaObjects/11064_2011_561_Fig8_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11064-011-0561-8/MediaObjects/11064_2011_561_Fig9_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11064-011-0561-8/MediaObjects/11064_2011_561_Fig10_HTML.gif
         isPartOf:
            name:Neurochemical Research
            issn:
               1573-6903
               0364-3190
            volumeNumber:36
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Junwei Ren
               affiliation:
                     name:The First Affiliated Hospital of Chongqing Medical University
                     address:
                        name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
                        type:PostalAddress
                     type:Organization
                     name:Chongqing Fuling Central Hospital
                     address:
                        name:Department of Neurology, Chongqing Fuling Central Hospital, Fuling District, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Cengceng Fan
               affiliation:
                     name:The First Affiliated Hospital of Chongqing Medical University
                     address:
                        name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Na Chen
               affiliation:
                     name:The First Affiliated Hospital of Chongqing Medical University
                     address:
                        name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jiagui Huang
               affiliation:
                     name:The First Affiliated Hospital of Chongqing Medical University
                     address:
                        name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qin Yang
               affiliation:
                     name:The First Affiliated Hospital of Chongqing Medical University
                     address:
                        name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Resveratrol Pretreatment Attenuates Cerebral Ischemic Injury by Upregulating Expression of Transcription Factor Nrf2 and HO-1 in Rats
      description:Oxidative stress damage plays a vital role in cerebral ischemia/reperfusion (I/R) pathogenesis. The nuclear factor erythroid 2-related factor 2 (Nrf2)/antioxidant response element (ARE) signaling pathway can be activated by pharmacological and dietary means to attenuate cellular oxidative stress. Resveratrol, a plant-derived polyphenolic compound, has antioxidant property. Recent studies have demonstrated that resveratrol has protective effects against cerebral I/R injury. However, little is known about its mechanism. Hence, this study identified the neuroprotective effect of resveratrol pretreatment and elucidate the Nrf2/ARE signaling mechanism after focal cerebral I/R injury in rats. Adult male Sprague–Dawley rats were randomly assigned to sham-operated group, ischemia/reperfusion physiological saline-treated group, and ischemia/reperfusion resveratrol-pretreatmented (15 and 30 mg/kg) groups. Rats were pretreatmented with resveratrol or physiological saline of corresponding volume administered intraperitoneally for 7 days before surgery and 30 min before middle cerebral artery occlusion. At 24 h after reperfusion, neurological score, infarct volume, and brain water content were assessed. Oxidative stress was evaluated by malondialdehyde (MDA) levels and superoxide dismutase (SOD) activity. Pathological changes of brain tissue were observed by HE staining. RT-PCR and Western blot analysed the expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1). TUNEL staining detected apoptotic cells. The protein expression of Caspase-3 were studied by immunohistochemistry. Resveratrol pretreatment significantly ameliorated neurological scores, reduced infarct volume and brain water content, decreased MDA levels, restored the SOD activity, upregulated the protein and mRNA expression of Nrf2 and HO-1, downregulated the protein expression of caspase-3. TUNEL-positive cells significantly decreased compared with the physiological saline-treated group. HE staining also showed that resveratrol significantly improved neuronal injury. These results showed that resveratrol pretreatment had neuroprotective effects on cerebral I/R injury. This neuroprotective effect is likely exerted by upregulated expression of transcription factor Nrf2 and HO-1 to ameliorate oxidative damage, decreased the protein expression of caspase-3. Our finding is important for understanding the neuroprotective mechanism of resveratrol and promoting its clinical therapeutic utility.
      datePublished:2011-08-18T00:00:00Z
      dateModified:2011-08-18T00:00:00Z
      pageStart:2352
      pageEnd:2362
      sameAs:https://doi.org/10.1007/s11064-011-0561-8
      keywords:
         Resveratrol
         Cerebral ischemia/reperfusion
         Oxidative stress
         Neuroprotection
         Nuclear factor erythroid 2-related factor 2 (Nrf2)
         Heme oxygenase 1 (HO-1)
         Caspase-3
         Neurosciences
         Neurochemistry
         Biochemistry
         general
         Cell Biology
         Neurology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11064-011-0561-8/MediaObjects/11064_2011_561_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11064-011-0561-8/MediaObjects/11064_2011_561_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11064-011-0561-8/MediaObjects/11064_2011_561_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11064-011-0561-8/MediaObjects/11064_2011_561_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11064-011-0561-8/MediaObjects/11064_2011_561_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11064-011-0561-8/MediaObjects/11064_2011_561_Fig6_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11064-011-0561-8/MediaObjects/11064_2011_561_Fig7_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11064-011-0561-8/MediaObjects/11064_2011_561_Fig8_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11064-011-0561-8/MediaObjects/11064_2011_561_Fig9_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11064-011-0561-8/MediaObjects/11064_2011_561_Fig10_HTML.gif
      isPartOf:
         name:Neurochemical Research
         issn:
            1573-6903
            0364-3190
         volumeNumber:36
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Junwei Ren
            affiliation:
                  name:The First Affiliated Hospital of Chongqing Medical University
                  address:
                     name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
                     type:PostalAddress
                  type:Organization
                  name:Chongqing Fuling Central Hospital
                  address:
                     name:Department of Neurology, Chongqing Fuling Central Hospital, Fuling District, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Cengceng Fan
            affiliation:
                  name:The First Affiliated Hospital of Chongqing Medical University
                  address:
                     name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Na Chen
            affiliation:
                  name:The First Affiliated Hospital of Chongqing Medical University
                  address:
                     name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jiagui Huang
            affiliation:
                  name:The First Affiliated Hospital of Chongqing Medical University
                  address:
                     name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qin Yang
            affiliation:
                  name:The First Affiliated Hospital of Chongqing Medical University
                  address:
                     name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Neurochemical Research
      issn:
         1573-6903
         0364-3190
      volumeNumber:36
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:The First Affiliated Hospital of Chongqing Medical University
      address:
         name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
         type:PostalAddress
      name:Chongqing Fuling Central Hospital
      address:
         name:Department of Neurology, Chongqing Fuling Central Hospital, Fuling District, Chongqing, China
         type:PostalAddress
      name:The First Affiliated Hospital of Chongqing Medical University
      address:
         name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
         type:PostalAddress
      name:The First Affiliated Hospital of Chongqing Medical University
      address:
         name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
         type:PostalAddress
      name:The First Affiliated Hospital of Chongqing Medical University
      address:
         name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
         type:PostalAddress
      name:The First Affiliated Hospital of Chongqing Medical University
      address:
         name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Junwei Ren
      affiliation:
            name:The First Affiliated Hospital of Chongqing Medical University
            address:
               name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
               type:PostalAddress
            type:Organization
            name:Chongqing Fuling Central Hospital
            address:
               name:Department of Neurology, Chongqing Fuling Central Hospital, Fuling District, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Cengceng Fan
      affiliation:
            name:The First Affiliated Hospital of Chongqing Medical University
            address:
               name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Na Chen
      affiliation:
            name:The First Affiliated Hospital of Chongqing Medical University
            address:
               name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Jiagui Huang
      affiliation:
            name:The First Affiliated Hospital of Chongqing Medical University
            address:
               name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Qin Yang
      affiliation:
            name:The First Affiliated Hospital of Chongqing Medical University
            address:
               name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
      name:Department of Neurology, Chongqing Fuling Central Hospital, Fuling District, Chongqing, China
      name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
      name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
      name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
      name:Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yuzhong District, Chongqing, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(195)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

Emails and Hosting {✉️}

Mail Servers:

mx.zoho.eu
mx2.zoho.eu
mx3.zoho.eu

Name Servers:

josh.ns.cloudflare.com
zita.ns.cloudflare.com

CDN Services {📦}

Crossref

4.81s.